| Target Price | HK$8.46 |
| Price | HK$4.89 |
| Potential |
73.10%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Grand Pharmaceutical 2027 .
The average Grand Pharmaceutical target price is HK$8.46.
This is
73.10%
register free of charge
HK$10.58
116.66%
register free of charge
HK$6.57
34.39%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Grand Pharmaceutical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Grand Pharmaceutical stock has an average upside potential 2027 of
73.10%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 12.28 | 12.91 |
| 5.48% | 5.07% | |
| EBITDA Margin | 18.63% | 21.32% |
| 20.34% | 14.45% | |
| Net Margin | 10.10% | 12.20% |
| 52.34% | 20.77% |
4 Analysts have issued a sales forecast Grand Pharmaceutical 2026 . The average Grand Pharmaceutical sales estimate is
This results in the following potential growth metrics:
3 Grand Pharmaceutical Analysts have issued a net profit forecast 2026. The average Grand Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.35 | 0.45 |
| 50.00% | 28.57% | |
| P/E | 10.87 | |
| EV/Sales | 1.66 |
3 Analysts have issued a Grand Pharmaceutical forecast for earnings per share. The average Grand Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Grand Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


